X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2575) 2575
Publication (136) 136
Book Review (125) 125
Patent (68) 68
Conference Proceeding (17) 17
Book Chapter (14) 14
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (974) 974
index medicus (912) 912
humans (877) 877
alzheimer's disease (813) 813
cerebrospinal fluid (705) 705
neurology (652) 652
male (625) 625
female (615) 615
neurovetenskaper (586) 586
aged (556) 556
biomarkers (502) 502
middle aged (459) 459
clinical neurology (414) 414
medicin och hälsovetenskap (363) 363
medical and health sciences (362) 362
dementia (348) 348
biomarkers - cerebrospinal fluid (345) 345
psychiatry (336) 336
alzheimer disease - cerebrospinal fluid (310) 310
mild cognitive impairment (295) 295
amyloid beta-peptides - cerebrospinal fluid (292) 292
diagnosis (288) 288
cerebrospinal-fluid (267) 267
aged, 80 and over (266) 266
neurologi (253) 253
tau proteins - cerebrospinal fluid (246) 246
brain (241) 241
clinical medicine (237) 237
klinisk medicin (234) 234
alzheimers-disease (233) 233
psykiatri (222) 222
peptide fragments - cerebrospinal fluid (215) 215
adult (213) 213
tau (203) 203
biological markers (198) 198
alzheimer disease (177) 177
alzheimer disease - diagnosis (174) 174
csf (161) 161
alzheimer’s disease (157) 157
biomarker (143) 143
pathology (143) 143
protein (141) 141
analysis (139) 139
proteins (134) 134
csf biomarkers (132) 132
research (132) 132
tau protein (132) 132
alzheimers disease (129) 129
neurodegenerative diseases (129) 129
mass spectrometry (117) 117
amyloid beta-protein (113) 113
article (113) 113
metabolism (108) 108
alzheimer disease - genetics (107) 107
risk factors (105) 105
enzyme-linked immunosorbent assay (104) 104
plasma (103) 103
abridged index medicus (102) 102
neurodegeneration (102) 102
tau proteins (101) 101
amyloid (99) 99
geriatrics & gerontology (98) 98
beta-amyloid (97) 97
genetics (96) 96
magnetic resonance imaging (96) 96
blood (93) 93
peptides (92) 92
amyloid-beta (90) 90
cohort studies (88) 88
disease (87) 87
phosphorylation (87) 87
amyloid precursor protein (86) 86
association (86) 86
medical research (85) 85
neuropsychological tests (85) 85
biomarkers - blood (84) 84
cognitive ability (84) 84
physiological aspects (84) 84
β-amyloid (84) 84
alzheimer disease - metabolism (83) 83
alzheimer disease - pathology (83) 83
physiology (83) 83
disease progression (82) 82
genotype (82) 82
mental disorders (80) 80
animals (79) 79
vascular dementia (79) 79
peptide fragments (75) 75
case-control studies (74) 74
geriatrics (74) 74
brain - pathology (73) 73
medicine (73) 73
testing (72) 72
80 and over (71) 71
a-beta (71) 71
frontotemporal dementia (71) 71
national institute (71) 71
physics (71) 71
follow-up studies (70) 70
medicine, experimental (69) 69
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2623) 2623
French (34) 34
Swedish (20) 20
German (19) 19
Spanish (4) 4
Norwegian (3) 3
Danish (2) 2
Greek (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2018, Volume 14, Issue 7, pp. P604 - P604
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 6, pp. 614 - 629
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2016, Volume 39, pp. S5 - S6
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 03/2016, Volume 39, p. S5-S6
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P878 - P879
Journal Article
Lancet Neurology, ISSN 1474-4422, 2006, Volume 5, Issue 3, pp. 228 - 234
Journal Article
Lancet Neurology, ISSN 1474-4422, 2009, Volume 8, Issue 7, pp. 619 - 627
Summary Background Alzheimer's disease (AD) pathology is common in patients with amnestic mild cognitive impairment (aMCI) without dementia, but the prevalence... 
Neurology | BIOMARKERS | DEPRESSION | INTERNATIONAL WORKSHOP | DEMENTIA | PHOSPHORYLATED-TAU | SUBTYPES | CLINICAL-DIAGNOSIS | CEREBROSPINAL-FLUID TAU | DIAGNOSTIC-CRITERIA | NORMATIVE DATA | CLINICAL NEUROLOGY | Predictive Value of Tests | Prevalence | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Alzheimer Disease - diagnosis | Sensitivity and Specificity | Amyloid beta-Peptides - cerebrospinal fluid | Female | Cognition Disorders - cerebrospinal fluid | Disability Evaluation | Severity of Illness Index | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Peptide Fragments - cerebrospinal fluid | Biomarkers - analysis | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Disease Progression | Neuropsychological Tests | Peptide Fragments - analysis | Cognition Disorders - diagnosis | Amyloid beta-Peptides - analysis | Aged | tau Proteins - analysis | Biomarkers - cerebrospinal fluid | Cohort Studies | Medical colleges | Medical research | Care and treatment | Neurosciences | Analysis | Medicine, Experimental | Diagnostic imaging | Alzheimer's disease | Prevalence studies (Epidemiology) | Index Medicus | Peptide Fragments | Biological Markers | MEDICIN OCH HÄLSOVETENSKAP | tau Proteins | MEDICAL AND HEALTH SCIENCES | diagnosis | Alzheimer Disease | analysis | Amyloid beta-Protein | physiopathology | Cognition Disorders | cerebrospinal fluid
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, pp. e33606 - e33606
Background: Sports-related head trauma is common but still there is no established laboratory test used in the diagnostics of minimal or mild traumatic brain... 
MILD | FOOTBALL | SPORTS | DIFFUSE AXONAL INJURY | FIBRILLARY ACIDIC PROTEIN | MULTIDISCIPLINARY SCIENCES | CHRONIC BRAIN-DAMAGE | CEREBROSPINAL-FLUID | CONCUSSION | S100B | LEAD | Prognosis | Prospective Studies | Follow-Up Studies | S100 Calcium Binding Protein beta Subunit | Humans | S100 Proteins - cerebrospinal fluid | Craniocerebral Trauma - diagnosis | Male | tau Proteins - cerebrospinal fluid | Case-Control Studies | Craniocerebral Trauma - etiology | Glial Fibrillary Acidic Protein - cerebrospinal fluid | Young Adult | Boxing - injuries | Transcription Factors - cerebrospinal fluid | Craniocerebral Trauma - cerebrospinal fluid | Adolescent | Adult | Female | Nerve Growth Factors - cerebrospinal fluid | Surveys and Questionnaires | Biomarkers - cerebrospinal fluid | Olympic athletes | Brain | Sports injuries | Boxing | Diagnosis | Biological markers | Injuries | Neurosciences | Nuclear magnetic resonance--NMR | Traumatic brain injury | Laboratories | S100b protein | Cerebrospinal fluid | Medical diagnosis | Subgroups | Proteins | Rest | Head injuries | Neurodegeneration | Questionnaires | Tomography | Physiology | Degeneration | Bioindicators | Injury analysis | Neurochemistry | Head | Cytokines | Soccer | Glial fibrillary acidic protein | Health risks | Trauma | Pathology | Hospitals | Concussion | Biomarkers | Brain damage | Marathons | Alzheimers disease | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN | Nuclear magnetic resonance | NMR
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2017, Volume 16, Issue 8, pp. 601 - 609
Summary Background Blood biomarkers of neuronal damage could facilitate clinical management of and therapeutic development for Huntington's disease. We... 
Neurology | DIAGNOSIS | FRONTOTEMPORAL DEMENTIA | CHAIN PROTEIN | CSF | AMYOTROPHIC-LATERAL-SCLEROSIS | CEREBROSPINAL-FLUID | PROGRESSION | CLINICAL NEUROLOGY | Brain - diagnostic imaging | Follow-Up Studies | Humans | Middle Aged | Atrophy - pathology | Cognitive Dysfunction - blood | Biomarkers - blood | Cognitive Dysfunction - etiology | Cognitive Dysfunction - physiopathology | Disease Progression | Trinucleotide Repeat Expansion | Huntington Disease - diagnostic imaging | Young Adult | Neurofilament Proteins - blood | Huntington Disease - genetics | Adult | Huntington Disease - blood | Aged | Retrospective Studies | Huntingtin Protein - genetics | Medicine, Experimental | Medical research | Medical colleges | Neurosciences | Analysis | Huntingtons disease | Neuroimaging | Plasma | Cognitive ability | Cerebrospinal fluid | Motor task performance | Blood | Proteins | Atrophy | Language | Neurodegeneration | Light | Trinucleotide repeat diseases | Polyglutamine | Trinucleotide repeats | Amyotrophic lateral sclerosis | Huntington's disease | Studies | Pathology | Magnetic resonance imaging | Biomarkers | Mutation | Ventricle | Alzheimers disease | Dementia | Index Medicus | Clinical Medicine | cerebrospinal-fluid | amyotrophic-lateral-sclerosis | csf | dementia | progression | diagnosis | frontotemporal | chain protein | Neurosciences & Neurology | Klinisk medicin
Journal Article
Journal of internal medicine, ISSN 1365-2796, 07/2018, Volume 284, Issue 6, p. 643
Accumulating data from clinical research support that the core Alzheimer disease (AD) cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ42), total-tau (T-tau),... 
Neurosciences | Neurovetenskaper
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | EPITOPE | IMAGING ABNORMALITIES | PEPTIDE | MOUSE MODEL | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Apolipoproteins | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article